AQA Stock Overview
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
AQA passed our risk checks.
Advanced Medical Solutions Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.10 |
| 52 Week High | UK£3.06 |
| 52 Week Low | UK£2.04 |
| Beta | 0.56 |
| 1 Month Change | -2.78% |
| 3 Month Change | -12.50% |
| 1 Year Change | -24.46% |
| 3 Year Change | -33.54% |
| 5 Year Change | -45.31% |
| Change since IPO | 1,621.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| AQA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.9% | -5.0% | -2.0% |
| 1Y | -24.5% | -13.6% | -0.3% |
Return vs Industry: AQA underperformed the German Medical Equipment industry which returned -13.6% over the past year.
Return vs Market: AQA underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| AQA volatility | |
|---|---|
| AQA Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AQA has not had significant price volatility in the past 3 months.
Volatility Over Time: AQA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 800 | Chris Meredith | www.admedsol.com |
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand.
Advanced Medical Solutions Group plc Fundamentals Summary
| AQA fundamental statistics | |
|---|---|
| Market cap | €472.57m |
| Earnings (TTM) | €18.42m |
| Revenue (TTM) | €146.28m |
25.7x
P/E Ratio3.2x
P/S RatioIs AQA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AQA income statement (TTM) | |
|---|---|
| Revenue | UK£126.21m |
| Cost of Revenue | UK£56.07m |
| Gross Profit | UK£70.14m |
| Other Expenses | UK£54.25m |
| Earnings | UK£15.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.073 |
| Gross Margin | 55.57% |
| Net Profit Margin | 12.59% |
| Debt/Equity Ratio | 0% |
How did AQA perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield32%
Payout RatioDoes AQA pay a reliable dividends?
See AQA dividend history and benchmarks| Advanced Medical Solutions Group dividend dates | |
|---|---|
| Ex Dividend Date | May 30 2024 |
| Dividend Pay Date | Jun 21 2024 |
| Days until Ex dividend | 36 days |
| Days until Dividend pay date | 58 days |
Does AQA pay a reliable dividends?
See AQA dividend history and benchmarks